Browse by author
Lookup NU author(s): Professor Herbie Newell
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The Laboratory Research Division (LRD) of the EORTC currently consists of five Groups with expertise that includes pre-clinical drug development, all aspects of cancer pharmacology, clinically-relevant receptor and biomarker studies, functional imaging and contemporary pathology. The LRD provides a Europewide resource for cancer clinical trials with particular expertise in the evolving field of translational research. In the development of therapies designed to exploit the molecular and cellular pathology of cancer, it is essential that translational research is included at all stages and the EORTC, through the LRD, has access to such expertise. In addition to providing support for drug development and clinical trials, the LRD represents a unique forum for the development of contemporary translational research expertise, the establishment of quality standards and the education of young laboratory and clinical scientists embarking on careers in oncology. © 2002 Elsevier Science Ltd. All rights reserved.
Author(s): Brünner N, Double J, Fichtner I, Gescher A, Newell D, Oosterhuis W, Price P
Publication type: Review
Publication status: Published
Journal: European Journal of Cancer
Year: 2002
Volume: 38
Issue: 4
Pages: S14-S18
ISSN (print): 0959-8049
ISSN (electronic): 1879-0852
URL: http://dx.doi.org/10.1016/S0959-8049(01)00455-5
DOI: 10.1016/S0959-8049(01)00455-5
PubMed id: 11858958
